---
figid: PMC10838672__MCO2-5-e474-g007
figtitle: JAK/STAT signaling and targeted inhibitors
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10838672
filename: MCO2-5-e474-g007.jpg
figlink: /pmc/articles/PMC10838672/figure/F5
number: F5
caption: Schematic of JAK/STAT signaling and targeted inhibitors. The JAK/STAT signaling
  pathways regulate gene expression and cell physiological functions such as cell
  proliferation, differentiation, cell metabolism, and immune response. Currently
  developed inhibitors mainly target JAK1‐3, TYK2, and STAT3. JAK, Janus‐kinase; STAT,
  signal transducer activator of transcription; SOCS, suppressor of cytokine signaling;
  TYK2, tyrosine kinase 2
papertitle: 'Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy'
reftext: Xiaoting Luo, et al. MedComm (2020). 2024 Feb;5(2).
year: '2024'
doi: 10.1002/mco2.474
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: John Wiley and Sons Inc.
keywords: hepatocellular carcinoma | immunotherapy | signaling pathways | targeted
  therapy
automl_pathway: 0.9373463
figid_alias: PMC10838672__F5
figtype: Figure
redirect_from: /figures/PMC10838672__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10838672__MCO2-5-e474-g007.html
  '@type': Dataset
  description: Schematic of JAK/STAT signaling and targeted inhibitors. The JAK/STAT
    signaling pathways regulate gene expression and cell physiological functions such
    as cell proliferation, differentiation, cell metabolism, and immune response.
    Currently developed inhibitors mainly target JAK1‐3, TYK2, and STAT3. JAK, Janus‐kinase;
    STAT, signal transducer activator of transcription; SOCS, suppressor of cytokine
    signaling; TYK2, tyrosine kinase 2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - CISH
  - STAT1
  - STAT4
  - STAT3
  - STAT5A
  - STAT6
  - STAT5B
  - STAT2
  - SOAT1
  - Tofacitinib
  - Pacritinib
  - Baricitinib
  - Ruxolitinib
  - Nucleus
---
